← Back to Search

2-Octyl Cyanoacrylate for Scar

N/A
Waitlist Available
Led By Daniel Eisen, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is investigating whether using surgical glue on top of wounds following skin surgery on the head or neck results in better cosmetic outcomes and if patients prefer this method of wound care.

Eligible Conditions
  • Scarring

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS)
Width of Scar as measured using Trace-to-Tape Method
Secondary outcome measures
Complications or Adverse Events from Treatment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Layered Closure with 2-Octyl CyanoacrylateExperimental Treatment1 Intervention
One half of the wound will have a cutaneous layer of sutures (2 layers), as is standard of care, while the other half of the wound will have an additional layer of 2-octyl cyanoacrylate (3 layers).
Group II: Layered ClosureActive Control1 Intervention
One half of the wound will have a cutaneous layer of sutures (2 layers), as is standard of care, while the other half of the wound will have an additional layer of 2-octyl cyanoacrylate (3 layers).

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
913 Previous Clinical Trials
4,709,693 Total Patients Enrolled
8 Trials studying Scarring
383 Patients Enrolled for Scarring
Daniel Eisen, MDPrincipal InvestigatorUniversity of California, Davis
8 Previous Clinical Trials
431 Total Patients Enrolled
4 Trials studying Scarring
200 Patients Enrolled for Scarring

Media Library

2-Octyl cyanoacrylate Clinical Trial Eligibility Overview. Trial Name: NCT05449457 — N/A
Scarring Research Study Groups: Layered Closure, Layered Closure with 2-Octyl Cyanoacrylate
Scarring Clinical Trial 2023: 2-Octyl cyanoacrylate Highlights & Side Effects. Trial Name: NCT05449457 — N/A
2-Octyl cyanoacrylate 2023 Treatment Timeline for Medical Study. Trial Name: NCT05449457 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any participants being accepted for this experiment?

"Presently, the clinical trial is actively enrolling participants. This study was first made available on October 6th 2022 and underwent an update last November 1st."

Answered by AI

How many people are currently enrolled in this clinical study?

"Affirmative, medical data on clinicaltrials.gov affirms that this trial is currently enrolling participants. The study was initially posted October 6th 2022 and the most recent update occurred November 1st 2022. This research requires 50 patients to be enrolled from a single clinic."

Answered by AI

Who else is applying?

What state do they live in?
Washington
What site did they apply to?
University of California, Davis - Dermatology Department
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
Recent research and studies
clinicaltrials.govStudy
Aesthetic Outcome of Layered Closure vs. Layered Closure Followed by 2-Octyl Cyanoacrylate
Daniel Eisen, MD 2022. "Aesthetic Outcome of Layered Closure vs. Layered Closure Followed by 2-Octyl Cyanoacrylate". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05449457.
~19 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top